Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Positive Atopic Dermatitis Data On Lilly's Newly-Approved Olumiant
Just Received European Green Light For Skin Disorder
Nov 02 2020
•
By
Kevin Grogan
Atopic dermatitis is a potentially lucrative market for Lilly • Source: Shutterstock
More from New Products
More from Scrip